7B27
RBD domain SARS-CoV2 in complex with neutralizing nanobody NM1230
This is a non-PDB format compatible entry.
Summary for 7B27
Entry DOI | 10.2210/pdb7b27/pdb |
Descriptor | Surface glycoprotein, neutralizing nanobody NM1230, 2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total) |
Functional Keywords | sars-cov2, receptor binding domain, complex structure, neutralizing nanobody, viral protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) More |
Total number of polymer chains | 4 |
Total formula weight | 81319.46 |
Authors | Ostertag, E.,Zocher, G.,Stehle, T. (deposition date: 2020-11-26, release date: 2021-05-12, Last modification date: 2024-01-31) |
Primary citation | Wagner, T.R.,Ostertag, E.,Kaiser, P.D.,Gramlich, M.,Ruetalo, N.,Junker, D.,Haering, J.,Traenkle, B.,Becker, M.,Dulovic, A.,Schweizer, H.,Nueske, S.,Scholz, A.,Zeck, A.,Schenke-Layland, K.,Nelde, A.,Strengert, M.,Walz, J.S.,Zocher, G.,Stehle, T.,Schindler, M.,Schneiderhan-Marra, N.,Rothbauer, U. NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies. Embo Rep., 22:e52325-e52325, 2021 Cited by PubMed: 33904225DOI: 10.15252/embr.202052325 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.902 Å) |
Structure validation
Download full validation report